Recommendations for the diagnosis and management of vaccine-induced immune thrombotic thrombocytopenia

Link to article at PubMed

S Afr Med J. 2021 Apr 20;111(6):535-537.


There have recently been safety concerns regarding an increased risk of vaccine-induced immune thrombotic thrombocytopenia (VITT) following administration of SARS-CoV-2 adenoviral vector vaccines. The Southern African Society of Thrombosis and Haemostasis reviewed the emerging literature on this idiosyncratic complication. A draft document was produced and revised by consensus agreement by a panel of professionals from various specialties. The recommendations were adjudicated by independent international experts to avoid local bias. We present concise, practical guidelines for the clinical management of VITT.


Leave a Reply

Your email address will not be published.